EUPRAXIA PHARMACEUTICALS INC. Depreciation
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Depreciation of $237.72 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-13
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $237.72K 40-F · filed 2026-03-13 |
| 2024-12-31 | $171.72K 40-F · filed 2026-03-13 |
| 2023-12-31 | $155.53K 40-F · filed 2025-03-20 |
| 2022-12-31 | $147.89K 40-F · filed 2024-04-01 |